English | Español

Community
+ Community
Press release submission | Oct 29, 2021

Banty's Dr. Richard Tytus Explains How to Have Successful Virtual Medicine Appointments with Patients
+ Regulatory
Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors
+ Community
Bob Martin | Oct 29, 2021

American Foundation for Suicide Prevention to spend $6.44 million on research this year
+ Technology/Innovation
Press release submission | Oct 28, 2021

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
+ Community
Karla Florez | Oct 28, 2021

FirstNet partners with AT&T to launch program for first responders who 'put their lives on the line every day'
+ Technology/Innovation
Bob Martin | Oct 27, 2021

Study shows 'promising new findings' for psilocybin therapy for depressed cancer patients
+ Community
Bob Martin | Oct 27, 2021

MLB players partner with Special Olympics for new workout campaign called 'Escuela de Fuerza'
+ Technology/Innovation
Press release submission | Oct 24, 2021

Surgery has survival benefits for male Stage IV breast cancer patients who are receptive to systemic therapy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation